{"text": "What are the main focus areas of the Blood Donor Selection Guidelines on Assessing Donor Suitability for Blood Donation?\n\nThe main focus areas include evidence-based practice, national health programs, and guidelines for assessing donor suitability for blood donation."}
{"text": "Which organization supported the development of the publication with a Cooperative Agreement Number PS024044?\n\nThe United States Centers for Disease Control and Prevention (CDC) supported the development of the publication."}
{"text": "Where can WHO publications be purchased from or requested for reproduction or translation?\n\nWHO publications can be purchased from WHO Press, World Health Organization, located at 20 Avenue Appia, 1211 Geneva 27, Switzerland, or can be requested for reproduction or translation through the WHO Press via their website."}
{"text": "Does the World Health Organization endorse specific companies or their products over others?\n\nNo, the World Health Organization does not endorse specific companies or their products over others."}
{"text": "How are the names of proprietary products indicated in the text?\n\nThe names of proprietary products are distinguished by initial capital letters."}
{"text": "What are the main components covered in the policy recommendations section of the document?\n\nThe policy recommendations section covers National system for blood donor selection, establishing a national system, national policy and legislative framework, national guidelines and criteria, public information and donor education, infrastructure and facilities."}
{"text": "How does the frequency of donation and iron supplementation relate to the provided passage?\n\nThe frequency of donation and iron supplementation are part of the considerations mentioned in the passage, which also includes fluid intake, food, and various health conditions affecting blood and iron levels."}
{"text": "What types of diseases are mentioned in the passage related to the central nervous system?\n\nThe passage mentions cerebrovascular disease, dementia and other neurodegenerative disorders, multiple sclerosis, and psychiatric disorders as types of diseases related to the central nervous system."}
{"text": "Why is a rigorous process to assess the suitability of prospective blood donors essential?\n\nTo protect the safety and sufficiency of the blood supply, safeguard the health of recipients of transfusion and blood donors themselves, and ensure that suitable donors are not deferred unnecessarily."}
{"text": "For what purpose have ODONATIONS been developed in relation to blood transfusion services?\n\nODONATIONS have been developed to assist blood transfusion services in countries that are establishing or strengthening national systems for the selection of blood donors."}
{"text": "When were the initial recommendations for safe blood donation practices developed, and what was the basis for these recommendations?\n\nThe initial recommendations for safe blood donation practices were developed in 1994, and they were based on international best practice, although they did not have a clear evidence base."}
{"text": "What is the purpose of the External Review Group (ERG) established by WHOBTS for the draft guidelines?\n\nThe purpose of the External Review Group (ERG) established by WHOBTS is to review and comment on the draft guidelines at various stages of the developmental process."}
{"text": "What are the two main parts of the guidelines presented for blood donor selection and donor counselling?\n\nThe guidelines are presented in two parts, with Part 1 addressing the requirements for an effective national system for blood donor selection and donor counselling, and Section 2 and 3 specifically focusing on the requirements for this system."}
{"text": "What types of blood components are included in the definition of blood donors according to the passage?\n\nBlood donors include donors of whole blood, red cells, platelets, plasma, and other blood components."}
{"text": "What process was followed to develop the blood donor selection guidelines according to the WHO?\n\nThe development process required a systematic review of new evidence for key questions and recommendations, consideration of programme feasibility, and the cost implications of potential new recommendations."}
{"text": "What was the purpose of creating the 'orts' in relation to blood donor selection?\n\nThe 'orts' were created to identify systematic literature reviews and evidence specifically related to blood donor selection in low and middle-income countries."}
{"text": "On what basis are the recommendations in the published document made when evidence is lacking?\n\nThe recommendations are made based on international best practices and the knowledge and expertise of members of the guideline development group and external review group in the fields of human physiology, pathology, and clinical medicine."}
{"text": "When will the review of the guidelines that were valid until 2017 take place?\n\nThe review of the guidelines that were valid until 2017 will take place to explore any new evidence, particularly in relation to controversial issues or where changes in practice may be appropriate."}
{"text": "What are the primary concerns for the safety and availability of blood and blood products for transfusion as mentioned in the passage?\n\nThe primary concerns include recruiting and selecting voluntary nonremunerated blood donors, ensuring the quality-assured screening of all donated blood, and addressing transfusion-transmissible infections."}
{"text": "What strategy does the World Health Organization recommend for ensuring the safety and availability of blood for clinical use?\n\nThe World Health Organization recommends an integrated strategy that includes the establishment of well-organized blood transfusion services coordinated at the national level, providing sufficient and timely supplies of safe blood from voluntary nonremunerated blood donors at low risk of infections transmitted through blood."}
{"text": "What measures are being implemented to ensure the safety and quality of donated blood for transfusions?\n\nThe measures include quality assured screening of all donated blood for transfusion-transmissible infections (HIV, hepatitis B, hepatitis C, and syphilis), blood grouping and compatibility testing, and the preparation of blood components. Additionally, rational use of blood is promoted to reduce unnecessary transfusions and minimize associated risks, with a preference for alternatives to transfusion where possible."}
{"text": "What should each country establish according to the passage for the donation of blood components?\n\nEach country should establish a national system for blood donor selection for the donation of whole blood, red cells, platelets, plasma, and other blood components."}
{"text": "Are the guidelines on blood donor selection applicable to all blood donation settings and donors?\n\nYes, the guidelines on blood donor selection are applied in every blood donation setting on each occasion of donation to all blood donors, including voluntary nonremunerated donors."}
{"text": "According to the passage, what is recommended for each country regarding blood donor selection?\n\nEach country should establish a national system for blood donor selection for the donation of blood or blood components."}
{"text": "On what basis should national donor selection guidelines and criteria be established according to the provided text?\n\nNational donor selection guidelines and criteria should be established based on epidemiological and scientific evidence, or on best practices when evidence is limited or lacking."}
{"text": "What are the national donor selection criteria intended to define in relation to blood donation?\n\nThe national donor selection criteria are intended to define the conditions of acceptance and deferral for each criterion related to blood donation."}
{"text": "What measures should be in place for the selection of blood donors according to the passage?\n\nMeasures for blood donor selection should include having selection criteria, staff training, and proper documentation in place."}
{"text": "What mechanisms should be included in the oversight of blood transfusion services for donor selection?\n\nThe mechanisms should include activities related to blood donor selection and encompass the equipment and consumables required for assessing the suitability of blood donors."}
{"text": "For how long should a recipient of blood and blood products be monitored following a transfusion?\n\nThe recipient should be monitored for 12 months following the transfusion."}
{"text": "After completing treatment for an acute attack of a certain condition, for how many days should a patient be referred to Section for monitoring?\n\nThe patient should be referred to Section for 14 days after full recovery from the acute attack and completion of treatment."}
{"text": "Under what conditions is a person considered permanently treated for a blood-related disorder?\n\nA person is considered permanently treated for a blood-related disorder if they have normal coagulation factor levels, no history of bleeding, and have not undergone treatment with blood products."}
{"text": "After undergoing which procedures must a patient with CJD and first-degree relatives be isolated for 7 days?\n\nAfter undergoing extraction or endodontic procedures, a patient with CJD and first-degree relatives must be isolated for 7 days."}
{"text": "After how many days of experiencing symptoms suggestive of a condition, should an individual be referred for evaluation if they have a history of injecting drug use?\n\nAn individual with a history of injecting drug use should be referred for evaluation after 28 days of experiencing symptoms suggestive of a condition."}
{"text": "What are the blood donation criteria regarding glycated hemoglobin (HbA1c) levels for individuals with a history of haemolysis?\n\nThe criteria for blood donation for individuals with a history of haemolysis require a glycated hemoglobin (HbA1c) level of not less than 7.0% for females and not less than 7.1% for males."}
{"text": "After fully recovering from genital herpes with no active lesions, for how many days should symptomatic individuals remain without active lesions before they are considered permanently infected if they have HHV8 and current or former sexual contacts?\n\nSymptomatic individuals should remain without active lesions for at least 28 days following full recovery before they are considered permanently infected if they have HHV8 and current or former sexual contacts."}
{"text": "After recovering from an active salmonella infection, for how long should an individual avoid close contact with others to prevent spreading the infection?\n\nThere is no specified duration in the passage for avoiding close contact after recovering from a salmonella infection to prevent spreading it. The passage provides guidelines for other infections and conditions."}
{"text": "For how long is the treatment for lymphoma considered in the provided passage?\n\nThe treatment for lymphoma is considered for the duration of the longest period of treatment mentioned in the passage."}
{"text": "For which conditions is it recommended to refer to Section for a period of 14 days following full recovery?\n\nThe conditions for which it is recommended to refer to Section for a period of 14 days following full recovery are not explicitly listed in the provided passage. However, the passage implies that certain medical conditions may require this follow-up period, as it mentions \"also refer to Section\" without specifying the conditions."}
{"text": "For how long should a patient with rheumatoid arthritis, psoriatic arthropathy, or ankylosing spondylitis wait after an invasive cosmetic procedure before they can refer to Section for treatment completion and recovery?\n\nThe patient should wait for 12 months following the last invasive cosmetic procedure before referring to Section for treatment completion and full recovery."}
{"text": "Under what conditions is ella infection considered permanent?\n\nElla infection is considered permanent if it is associated with chronic or recurrent infection, causes chronic renal disease leading to ill-health or anaemia, or is linked with chronic or recurrent respiratory infections that persist for more than 14 days after full recovery."}
{"text": "For how long should a patient be referred to Section after completing treatment for acute Q fever and achieving full recovery?\n\nA patient should be referred to Section for 2 years following completion of treatment and full recovery for acute Q fever."}
{"text": "After recovering from a systemic disease affecting the skin, for how long should one refer to the relevant sections for follow-up care?\n\nFor 28 days following full recovery, and for 14 days following full healing if recent superficial but significant wounds."}
{"text": "Under what conditions is a permanent splenectomy indicated following a splenectomy?\n\nA permanent splenectomy is indicated if the patient has thrombocytopenia of unknown cause or is associated with long-term hematological or systemic disease."}
{"text": "For how long should a patient be monitored after transplantation of allogeneic tissues for malignant thyroid tumours?\n\nA patient should be monitored for 2 years following confirmation of cure after transplantation of allogeneic tissues for malignant thyroid tumours."}
{"text": "What is the primary responsibility of the BTS in relation to blood donation?\n\nThe primary responsibility of the BTS is to provide a safe, sufficient, and timely supply of blood and blood products, ensuring the act of blood donation is safe and causes no harm to the donor, and maintaining a pool of safe, voluntary nonremunerated blood donors."}
{"text": "Why is it necessary to assess the suitability of prospective blood donors on each occasion of donation?\n\nIt is necessary to assess the suitability of prospective blood donors on each occasion of donation to protect the donor's health and safety, ensure patient safety, and identify any factors that might make an individual unsuitable as a donor, either temporarily or permanently."}
{"text": "How many units of blood are discarded annually worldwide due to infectious markers for transfusion-transmissible infections (TTI)?\n\nAn estimated number of units are discarded, but the exact figure is not provided in the passage."}
{"text": "What are the reasons for deferring at least 13 million prospective blood donors from donating blood?\n\nThe reasons for deferring these prospective donors include anaemia, existing medical conditions, and the risk of infections that could be transmitted through transfusion."}
{"text": "How are donor selection criteria managed across different countries according to the passage?\n\nThere are significant variations between countries in the management of donor selection criteria. Some countries have well-developed national systems with clearly defined and uniformly applied donor selection criteria, while others lack well-developed systems and have criteria that are not clearly defined or consistently applied."}
{"text": "How can improper donor assessment affect the health of blood recipients and the safety of blood transfusions?\n\nImproper donor assessment can lead to collecting blood from donors who are not suitable to donate, which may negatively impact the health of recipients and increase the risk of transmitting infections through transfusions."}
{"text": "What factors should policies for donor selection consider according to the passage?\n\nPolicies for donor selection should consider the need for a balance between the safety and sufficiency of the blood supply and the available resources."}
{"text": "What are the main focuses of the World Health Assembly resolution 15 in 2010 regarding blood donation?\n\nThe main focuses of the World Health Assembly resolution 15 in 2010 regarding blood donation are the retention and motivation of voluntary, nonremunerated blood donors, the implementation of strict criteria for donor selection, and the urging of Member States to update their national regulations on donor assessment and deferral."}
{"text": "What is the primary aim of establishing blood donor selection guidelines?\n\nThe primary aim is to guide and support countries in creating effective national systems for blood donor selection to ensure the safety of blood recipients and protect donor health."}
{"text": "What are the specific objectives of the guidelines for blood donor selection?\n\nThe specific objectives are to provide guidance on measures needed to develop and implement effective systems for assessing the suitability of individuals to donate blood, and to review the available evidence base and provide recommendations on criteria for blood donor selection."}
{"text": "What types of blood components are included in the donor selection criteria according to the guidelines?\n\nThe donor selection criteria include whole blood, red cells, platelets, plasma, and other blood components."}
{"text": "Why should the issue of sufficiency be considered when developing national guidelines for blood transfusion services?\n\nThe issue of sufficiency should be considered to balance the risk of infection against the risk of blood shortages that could result from overly stringent guidelines."}
{"text": "How are elines developed according to the needs of each country?\n\nElines are developed based on the specific circumstances and needs of each country."}
{"text": "Which types of organizations and institutions are involved in blood donor education and recruitment according to the guidelines?\n\nBlood donor organizations, nongovernmental organizations, professional societies, patient associations, and institutions involved in education and training are involved in blood donor education and recruitment."}
{"text": "What are the three main components of an effective national system for assessing the suitability of prospective blood donors as identified by the WHO Safety program in 2009?\n\nThe three main components are defining the content and assessing the topics for recommendations on blood donor selection, identifying the components of an effective national system for assessing the suitability of prospective donors, and establishing criteria for the acceptance or deferral of prospective donors."}
{"text": "What are the criteria for accepting or deferring prospective blood donors to ensure both donor health and safety and the avoidance of unnecessary deferrals?\n\nThe criteria for accepting or deferring prospective blood donors are established to protect donor health and safety and to prevent unnecessary deferrals of suitable donors. These criteria are developed by a guideline development group with specialist expertise in haematology, transfusion medicine, and blood donor management."}
{"text": "What are the responsibilities of the GDG in collaboration with WHOBTS regarding evidence assessment and synthesis?\n\nThe GDG, along with WHOBTS, is responsible for identifying priority questions, retrieving evidence, assessing and synthesizing evidence, identifying controversial issues or where practice change is recommended, reviewing internationally recognized guidelines and current practices worldwide, formulating recommendations, preparing the text, and planning for dissemination, implementation, and impact evaluation."}
{"text": "What is the purpose of the external review group (ERG) established by WHOBTS, and who comprises its members?\n\nThe external review group (ERG) was established to ensure a wide range of specialist expertise and experience from blood transfusion services in all regions. Its members include experts from the WHO Expert Advisory Panel on Medicine, WHO Collaborating Centres in Transfusion Medicine, directors of national blood transfusion services, and blood programme managers from each WHO region."}
{"text": "What was the primary responsibility of the ERG in the development of the guidelines?\n\nThe primary responsibility of the ERG was to review the draft guidelines and advise WHO on their relevance and applicability in their countries, considering factors such as epidemiology, risk behaviors, cultural practices, and available blood screening and confirmatory testing technologies."}
{"text": "How did the WHO Guidelines Review Committee contribute to the development of the guidelines?\n\nThe WHO Guidelines Review Committee reviewed the guidelines, provided guidance on evidence retrieval and assessment, ensuring the evidence was unbiased, up-to-date, and relevant. They also addressed detailed comments systematically, leading to modifications in the guidelines."}
{"text": "When and where was the advanced draft of the guidelines for blood donor selection and counselling developed, and which regions were considered priority?\n\nThe advanced draft of the guidelines was developed during an interregional workshop in June 2011 in Nairobi, Kenya. The priority regions considered were the African and Eastern Mediterranean regions."}
{"text": "What criteria were considered in 2012 for determining the suitability of individuals for blood donation based on physiological conditions, diseases, and risk behaviors?\n\nThe criteria considered included physiological conditions, diseases, and risk behaviors in relation to the suitability of individuals for blood donation."}
{"text": "From which regions were the literature searches specifically designed to collect information in the context of blood donor selection systems?\n\nThe literature searches were specifically designed to collect information from low and middle income countries, including regions such as Africa, the Eastern Mediterranean, South East Asia, and the Western Pacific Region."}
{"text": "What is the focus of the grey literature retrieval using Google and Yahoo as mentioned in the passage?\n\nThe focus of the grey literature retrieval is on the existence and availability of national guidelines and criteria for blood donor selection, as well as the current practice in blood donor selection in countries."}
{"text": "What methodologies were employed to retrieve relevant citations on each topic from various databases?\n\nThe methodologies included using MeSH terms, medical subject heading terms, key authors, and institutions. A detailed search strategy was documented with the date and time of the search, the number of databases searched, the keywords and MeSH terms used, and the search strings. Additionally, a preliminary screen was conducted by reviewing titles to eliminate irrelevant and duplicate citations."}
{"text": "How was the selection of key papers for the study conducted?\n\nThe selection of key papers was done by the chair of the GDG who reviewed titles and abstracts, and then selected papers that addressed each study question. The full text of these papers was also reviewed for quality of evidence and other assessments."}
{"text": "What formed the basis for the recommendations on criteria for the acceptance and deferral of prospective blood donors?\n\nThe paucity of high-quality evidence on which to base decisions on blood donor selection formed the basis for the recommendations."}
{"text": "What are the foundations of the longest-established donor selection criteria?\n\nThe foundations of the longest-established donor selection criteria are based on medical knowledge of the disease process and human physiology, the hemodynamic effect of blood donation, and the potential for harm to either the donor or the recipient."}
{"text": "On what basis are the selection criteria for blood donors primarily founded?\n\nThe selection criteria for blood donors are primarily based on general medical principles aimed at minimizing any risk to the donor or recipient."}
{"text": "What factors does the GRADE system consider when assessing the quality of evidence?\n\nThe GRADE system considers factors such as study design, quality, consistency, directness, and precision when assessing the quality of evidence."}
{"text": "On what basis are recommendations for donor selection criteria made when published evidence is lacking?\n\nRecommendations for donor selection criteria are made based on international best practice and the medical knowledge and expertise of members of the guideline development group and external review group."}
{"text": "What are the main topics covered in Part 1 of the document regarding blood donor selection policy?\n\nPart 1 of the document covers requirements for an effective national system for blood donor selection policy and provides recommendations on pp. 12."}
{"text": "When is the WHO Safety Team scheduled to review the guidelines mentioned in the passage?\n\nThe WHO Safety Team is scheduled to review the guidelines at the time when the guidelines are anticipated to remain valid, which is until 2017."}
{"text": "What are the key components included in the national system for blood donor selection?\n\nThe national system for blood donor selection includes national policy and legislative framework, national guidelines and criteria on blood donor selection, public information and donor education, suitable infrastructure and facilities, adequate financial and human resources, quality system with standard operating procedures, documentation, and records, donor haemovigilance, monitoring, and evaluation."}
{"text": "What key elements should a national blood policy include according to the passage?\n\nA national blood policy should define strategies for blood donor recruitment, selection, deferral, blood screening for TTI, confirmatory testing, donor notification, counselling, and referral. It should also be supported by a legislative and regulatory framework and implemented through national guidelines."}
{"text": "What are the responsibilities of BTS in relation to blood donors and recipients?\n\nBTS is responsible for protecting the health and safety of blood donors, ensuring confidentiality, privacy, self-determination, and nondiscrimination. Additionally, BTS must safeguard the health of recipients of blood and blood products, ensuring their safety, quality, and availability."}
{"text": "What rights do patients have regarding blood transfusions?\n\nPatients have the right to be protected from avoidable adverse effects of transfusion."}
{"text": "Who should be involved in the consultation process to develop and periodically review the guidelines and criteria on blood donor selection?\n\nThe consultation process should involve key stakeholders such as national policy makers, National blood programme managers, Senior BTS personnel, experts in transfusion medicine and science, clinical users of blood, microbiologists, social scientists, and representatives of the regulatory agency."}
{"text": "How does the BTS's implementation of donor selection criteria benefit both blood donors and recipients of transfusion?\n\nThe BTS's implementation of donor selection criteria protects the health of blood donors and recipients of transfusion, maintains and raises standards of donor management and care, and minimizes unnecessary donor deferrals."}
{"text": "What factors should national guidelines for blood donor selection criteria consider according to the passage?\n\nNational guidelines for blood donor selection criteria should consider evidence and risk assessment, national data on the epidemiology of medical conditions and transfusion-transmissible infections, and risk behaviors."}
{"text": "Why should national guidelines and criteria on blood donor selection be regularly reviewed and updated?\n\nNational guidelines and criteria on blood donor selection should be regularly reviewed and updated in response to changes in epidemiology, advances in technology, the latest medical and scientific information, new evidence, emerging infections, and other situations that may influence donor and patient safety."}
{"text": "What factors should be considered when revising donor selection criteria to ensure both donor and recipient safety and adequate blood supply?\n\nFactors to consider include balancing donor acceptance and deferral criteria with blood screening procedures, and assessing the potential relaxation of donor selection criteria during emergency situations to maintain adequate blood supplies."}
{"text": "What is the purpose of a donor questionnaire in the context of blood donation?\n\nThe purpose of a donor questionnaire is to assess donor health and safety and to reduce the risk of transmission of infections, especially for those infections for which no suitable screening tests are available."}
{"text": "Why is a standardized donor questionnaire considered important in the donation process?\n\nA standardized donor questionnaire is important because it ensures uniformity and consistency in the approach to assessing donor suitability, facilitates ease of implementation in collecting systematic information about each donor on every donation occasion, and forms the basis for a confidential one-to-one interview with a trained staff member. It also prompts staff to ask crucial questions and carefully evaluate the donors' health."}
{"text": "What is the primary purpose of a standard donor questionnaire?\n\nThe primary purpose of a standard donor questionnaire is to facilitate decisions on the acceptance or deferral of the donor."}
{"text": "Why is it important to pilot and validate a donor selection questionnaire before use?\n\nIt is important to pilot and validate a donor selection questionnaire to ensure that all ambiguity is removed and that it yields the expected results, thereby facilitating accurate responses from donors."}
{"text": "Why is it important to revise donor questionnaires in accordance with changes in national guidelines?\n\nIt is important to revise donor questionnaires to ensure they align with the updated selection criteria in the national guidelines, which helps maintain the uniformity and effectiveness of blood donation settings."}
{"text": "How do gns and donor information materials benefit potential blood donors?\n\nThey help ensure that individuals who volunteer as blood donors are well-informed, likely to be accepted, and understand the health conditions and risk behaviors that could make them unsuitable donors."}
{"text": "Is it permissible to discriminate against potential blood donors based on gender, race, or religion according to the guidelines mentioned in the passage?\n\nNo, it is not permissible to discriminate against potential blood donors based on gender, race, or religion as per the guidelines provided in the passage."}
{"text": "Why is it important for the materials explaining the rationale and objectives of blood donation to be simple and written in suitable languages?\n\nIt is important for the materials to be simple and written in suitable languages to ensure they are easily understandable by the donor population."}
{"text": "Why is a pleasant atmosphere important for blood donation centers?\n\nA pleasant atmosphere is important for blood donation centers because it encourages donors to relax and helps to reduce their anxiety."}
{"text": "Why is a system of adequate and sustainable finances important for a blood donation service?\n\nA system of adequate and sustainable finances is important for a blood donation service to ensure a stable and sufficient supply of safe blood and blood products."}
{"text": "What is the purpose of assessing donor suitability and how does effective donor education contribute to this process?\n\nThe purpose of assessing donor suitability is to minimize the collection of blood from unsuitable donors, which in turn reduces the wastage of blood, consumables, and donor and staff time. Effective donor education, recruitment, and selection are crucial in achieving this goal."}
{"text": "What qualifications and skills are required for staff working in donor selection for blood donation?\n\nStaff working in donor selection should be appropriately qualified, well-trained, and skilled in providing information, advice, and counselling to assess donor suitability. They should have an understanding of the principles and basis for donor selection criteria and possess the technical and clinical skills required to perform health and risk assessments. Key skills, knowledge, and competencies include understanding of the donor selection process."}
{"text": "What are the key components included in the pre-donation information and counselling process?\n\nThe pre-donation information and counselling process includes interview and assessment based on a standardized donor questionnaire, ensuring the ability to explain questions in the donor questionnaire to ensure understanding and allay donors' apprehensions, a basic health check that includes haemoglobin screening, and counselling of deferred donors."}
{"text": "What are some essential elements of a quality system in the donor selection process?\n\nEssential elements include an organizational structure defining authority, responsibility, and reporting channels; written job specifications; donor selection criteria as part of national guidelines; and standard operating procedures (SOPs) to guide every process."}
{"text": "What are the key components included in the procedure and task to ensure donor adherence and consistency?\n\nThe key components include information on necessary staff, facilities, forms, worksheets, and references; a standardized donor questionnaire; a basic health check with haemoglobin screening; staff training and competency assessment with a training curriculum and records; and a traceable records system, either electronic or manual."}
{"text": "What types of records and health screenings are associated with each donation at the donation center?\n\nEach donation is associated with donor records, including completed donor questionnaires, results of basic health check, and haemoglobin screening."}
{"text": "How should the instruments and equipment used in the donor selection process be maintained?\n\nThey should be maintained and calibrated in accordance with quality requirements."}
{"text": "Why is the continuous process of data collection and analysis of adverse donor events and reactions important in donor haemovigilance?\n\nThe continuous process of data collection and analysis of adverse donor events and reactions is important in donor haemovigilance to investigate their causes and outcomes, and to utilize the haemovigilance data for clinical and public health decision making."}
{"text": "Why is it important for donors to inform the BTS about any effects they experience after donating blood?\n\nIt is important for donors to inform the BTS about any effects they experience after donating blood to enable regular analysis of the data, which can lead to possible corrective and preventive actions. This is part of the goal of donor hemovigilance, which aims to reduce adverse events and reactions and improve outcomes for both donors and patients."}
{"text": "What is the timeframe within which donors must be monitored for illness after donating, and why is this important?\n\nDonors must be monitored for illness within 28 days of donation because it is crucial to identify and address any infections they may have been incubating at the time of donation, which is vital for preventing the transmission of diseases like hepatitis A to the recipient."}
{"text": "What measures are suggested to improve patient safety in the context of organ donation and transplantation?\n\nThe measures suggested include tracing of donors and withdrawal of donations that may cause serious adverse reactions in recipients, improved patient safety through better donor selection criteria and processes, epidemiological follow-up of the donor population, and a rapid response system to share information related to adverse donor events and reactions."}
{"text": "Why is it important for ansfusion to be fed back into the donor haemovigilance system?\n\nIt is important for ansfusion to be fed back into the donor haemovigilance system to improve donor selection."}
{"text": "What methods are considered for assessing the effectiveness of blood donor selection?\n\nQuantitative and qualitative data collection methods, including focus group discussions, are considered for assessing the effectiveness of blood donor selection."}
{"text": "Why should donor selection criteria and reasons for donor deferrals be regularly evaluated?\n\nThey should be evaluated to identify if any criteria need to be removed, modified, or extended to improve the protection of donors and recipients and to minimize the deferral of suitable donors. Additionally, the application of these criteria should be monitored to ensure correct interpretation and to identify areas needing additional staff training."}
{"text": "How do the prevalence rates of infection in blood donors, categorized by age and gender, contribute to the management of blood donation processes?\n\nThe prevalence rates of infection in blood donors, when broken down by age and gender, contribute to a better understanding of donor behavior and risk assessment. This information is crucial for updating donor selection, deferral, and blood screening strategies to ensure they are current and effective."}
{"text": "How can the provided information assist in understanding and improving the donor education process and selection criteria?\n\nThe information can help understand patterns of infection in asymptomatic individuals, evaluate the effectiveness of donor education and selection criteria, and improve the donor education process and selection by providing insights into the routes of infection and the sufficiency of donor education materials regarding TTI risk."}
{"text": "What percentage of individuals were deferred from donating blood due to low haemoglobin levels?\n\nThe passage does not specify the percentage of individuals deferred due to low haemoglobin levels. It only lists low haemoglobin as one of the reasons for deferral."}
{"text": "What percentage of donors self-deferred following donor assessment and counseling?\n\nThe passage does not specify the exact percentage of donors who self-deferred following donor assessment and counseling."}
{"text": "What aspects of the donor selection process are considered for improvement according to the passage?\n\nThe aspects considered for improvement in the donor selection process include enhancing the effectiveness of donor education, assessing the sensitivity of donor selection criteria, and identifying mechanisms for improving the process of donor selection through operational research."}
{"text": "What are some key considerations for formulating donor questionnaires to ensure cultural sensitivity and understanding?\n\nKey considerations include ensuring the specificity and cultural sensitivity of questions, verifying that donors understand the questionnaire, and implementing strategies to increase adherence to selection criteria, reduce blood discard rates, and improve donor retention."}
{"text": "What are the key principles of blood donor selection mentioned in the passage?\n\nThe key principles include safeguarding the health and safety of both the donor and the recipient, ensuring only individuals in good health donate, and planning the selection process to efficiently use staff and donor time while making donation convenient and minimizing long waiting periods."}
{"text": "On what basis should the selection of blood donors be made according to the passage?\n\nThe selection of blood donors should be based on regularly reviewed selection criteria, without discrimination of any kind including gender, race, nationality, or religion."}
{"text": "What are the responsibilities of the BTS staff in the donor selection process?\n\nThe BTS staff should be suitably qualified and trained, establish good communication with the donor, ensure donor confidentiality, provide counselling to deferred donors, and refer them for further management."}
{"text": "What are the steps involved in the donor selection process before blood collection?\n\nThe steps involved in the donor selection process before blood collection include donor registration, predonation information collection, completion of a donor questionnaire, a donor interview with predonation counselling, a donor health and risk assessment, and obtaining consent."}
{"text": "What are the steps involved in the registration and preparation process for a blood donor?\n\nThe steps involved in the registration and preparation process for a blood donor include registration, pre-donation information, self-deferral, completion of the donor questionnaire, donor interview and pre-donation counseling, donor health and risk assessment, ance for blood donation, and retention of nonreactive donors as regular donors with reinforcement of healthy lifestyles."}
{"text": "Why is compliance with donor selection criteria important in the blood donation process?\n\nCompliance with donor selection criteria is important to ensure a safe blood donation process and outcomes, protecting both the health of the donors and the patients who receive transfusions."}
{"text": "What essential information is collected during a donor's initial registration for blood donation?\n\nDuring the initial registration for blood donation, essential information collected includes the individual's full name, date of birth, gender, and contact details. Additionally, a unique donor number is assigned at the time of first registration."}
{"text": "What is included in the donor registration process during blood donation?\n\nThe donor registration process includes providing prospective donors with donor information and education materials, the donor questionnaire, and ensuring that it is completed on each occasion of donation."}
{"text": "What is the purpose of providing pre-donation information to prospective blood donors?\n\nThe purpose of providing pre-donation information is to inform prospective donors about health conditions or high-risk behaviors that could make them unsuitable to donate blood. This helps donors decide whether to defer donation and may assist in their return if they understand the reasons for not being able to donate."}
{"text": "What are the objectives of providing predonation information to potential blood donors?\n\nThe objectives of providing predonation information are to increase donor awareness of donor selection criteria, the blood donation process, and the tests performed on donated blood; encourage prospective donors to inform the BTS of any medical conditions or risks related to transmissible infections that may affect their suitability to donate; and encourage individuals to self-defer from blood donation if they recognize they are not suitable due to general health concerns."}
{"text": "What aspects should predonation information cover regarding blood donation?\n\nPredonation information should cover the nature and use of blood and its components, the need for voluntary non-remunerated blood donors, and the importance of maintaining healthy lifestyles. It should also include details about the blood donation process, donor questionnaire, medical history, health and risk assessment, venepuncture, blood collection methods, postdonation care, and the screening tests performed on donated blood."}
{"text": "What are the responsibilities of donors in the blood donation process?\n\nDonors have responsibilities such as deciding about blood donation prior to proceeding, the option to withdraw or self-defer at any time during or after the donation process, and understanding their rights. They also need to be aware of transfusion-transmissible infections, their routes of transmission, natural history, and prevention methods."}
{"text": "What are the possible consequences for donors and the donated blood if the TTI test results are abnormal?\n\nThe possible consequences include notification about abnormal test results, postdonation counseling, assurance of confidentiality, and if necessary, referral for further testing, treatment, and care. There is also a consideration for the possibility of adverse donor reactions."}
{"text": "Why should an effective blood donor complete a donor questionnaire before the donation process?\n\nAn effective blood donor should complete a donor questionnaire to provide information in relation to the donor selection criteria defined in the national guidelines, which helps in the donation process."}
{"text": "How is the donor questionnaire administered during the ood donation session?\n\nThe donor questionnaire can be administered either in person or electronically as a computer-based questionnaire."}
{"text": "Why is it essential for donors to be aware of the importance of the questionnaire and the need for providing accurate information?\n\nIt is essential for donors to be aware of the importance of the questionnaire and the need for providing accurate information because the information they provide can then be used effectively."}
{"text": "What is the purpose of the completed donor questionnaire review during a donor interview?\n\nThe purpose of reviewing the completed donor questionnaire during a donor interview is to assess the donor's general health, medical history, and any transmissible tumor (TTI) risks. It also allows the staff to ensure the donor has understood and correctly answered the questions."}
{"text": "Why is it important for donors to understand the significance of providing accurate and complete health information when giving blood?\n\nIt is important for donors to understand the significance of providing accurate and complete health information to ensure their own welfare is considered important by the BTS, which may also motivate them to donate blood."}
{"text": "How should the ability of donors to understand the blood donation process be assessed?\n\nThe ability of donors to understand the blood donation process should be assessed by evaluating their informed consent."}
{"text": "When is donor selection staff involved in the donor interview process?\n\nDonor selection staff are involved during the donor interview process to provide Predonation counselling, which includes checking the donor's understanding of questions, answering their queries, offering reassurance, explaining deferrals, advising on further medical care if needed, and ensuring informed consent for donation."}
{"text": "Why is it important for the assessment of donor health and TTI risks to be conducted with privacy and a nonjudgmental approach?\n\nThe assessment of donor health and TTI risks needs to be conducted with privacy and a nonjudgmental approach to ensure the donor feels comfortable and secure, which encourages honesty in their responses and upholds the assurance of confidentiality."}
{"text": "What is the risk associated with TTI in relation to blood donations?\n\nThe risk is particularly high for Transfusion Transmitted Infection (TTI) from donors with recently acquired infections that are undetectable by routine screening tests or for which no effective blood screening tests are available."}
{"text": "What aspects of a donor's health are assessed during the basic health check in the physical examination process?\n\nDuring the basic health check in the physical examination process, the donor's health is assessed by checking for signs of debility, undernutrition, pallor, jaundice, cyanosis, dyspnoea, or intoxication from alcohol or drugs. Additionally, vital signs such as pulse, blood pressure, and weight are measured."}
{"text": "What factors should be considered during a donor health and risk assessment to ensure a smooth donation process?\n\nDuring a donor health and risk assessment, factors such as the accessibility and suitability of donors' veins for easy venepuncture, the presence of any physical disabilities that may impede the donation process (like mobility issues), and the need for sight or hearing impairment assistance should be considered to ensure a smooth donation process."}
{"text": "What measures can be taken to ensure a donor's comfort when answering sensitive questions during the donation process?\n\nTo ensure a donor's comfort, sufficient privacy and assurance of confidentiality should be provided. Additionally, overcoming language barriers, using simple language, and explaining medical terms can help in good communication and make the donor feel at ease."}
{"text": "What are the uses of the donated blood as per the informed consent provided by the BTS?\n\nThe uses of the donated blood include transfusion to patients, testing for Transfusion-Transmitted Infections (TTI) and other tests on the samples taken from the donated blood, as well as potential uses for additional tests, quality assurance, or research purposes."}
{"text": "Why is informed consent important for a blood donor before donating blood or blood components?\n\nInformed consent is important because it signifies that the donor has understood the questionnaire, provided accurate answers, and is willing to donate blood voluntarily. It also indicates that the donor understands the blood donation process, the possibility of adverse reactions, and the risks involved."}
{"text": "What are the potential consequences for blood donors if they provide incorrect information on the donation questionnaire in certain countries?\n\nIn certain countries, donors may be held legally liable if they provide incorrect information on the donation questionnaire."}
{"text": "Under what conditions can minors donate blood, and what is required from them before the donation?\n\nMinors under the legal age of majority can donate blood if they obtain written consent from a parent or guardian, and this is done in accordance with national requirements."}
{"text": "Why should deferred donors be informed about the reason for their deferral?\n\nDeferred donors should be informed whether the deferral is to safeguard their own health or that of the recipient."}
{"text": "Why might donors not return to donate blood after being temporarily deferred?\n\nDonors might not return to donate blood after being temporarily deferred because they may not spontaneously seek follow-up medical care if the information given about the reason for deferral is unclear or unsatisfactory."}
{"text": "Why should the donor's general health, medical history, and TTI risk assessment record be signed by the donor?\n\nThe record should be signed by the donor to confirm its correctness, as it becomes part of the donor's records, documenting informed consent."}
{"text": "What key information should donor records include according to the passage?\n\nDonor records should include information on donor deferrals, adverse reactions or unexpected events, unsuccessful donations, and allow traceability from the donor to the patient receiving transfusion and vice versa."}
{"text": "Why is it important to analyze adverse donor events and reactions during the donor selection process?\n\nAnalyzing adverse donor events and reactions is important to monitor the effectiveness of donor selection and to take necessary remedial action."}
{"text": "Why is it important to collect and regularly review data on donor deferrals?\n\nIt is important to collect and regularly review data on donor deferrals to enable the BTS to assess the major causes of deferral, especially those leading to the most significant numbers of deferrals and those posing high risks to patients. This helps in making relevant decisions based on local data, as the most common causes of deferral vary from country to country."}
{"text": "How does a donor deferral registry (DDR) benefit the process of donor selection and education?\n\nA donor deferral registry benefits the process by indicating if donor information and education need improvement, if donor selection criteria should be reviewed, ensuring staff interpret guidelines correctly, identifying where further education and training are needed, and by enabling the checking of previous deferral statuses to make decisions on reentry of temporarily deferred donors."}
{"text": "What is the purpose of a Donor Deferral Record (DDR) in the context of transfusion-transmissible infections?\n\nThe DDR is used to monitor the incidence and prevalence of transfusion-transmissible infections in the donor population and to help identify areas that need improvement in the donor selection process."}
{"text": "Why might the blood of some donors be considered unsafe for transfusion, and what measures are in place to prevent its use?\n\nThe blood of some donors might be unsafe for transfusion if they have been persuaded or coerced to donate. To prevent this, the Controlled Use of Eligible Donors (CUE) system is implemented, where donors are informed about how to contact the BTS to indicate that their blood should not be used for transfusion. This system aims to enhance the safety of the donor selection and blood screening processes."}
{"text": "How does the use of the Edinburgh criteria potentially affect the management of donors and the perception of staff responsibility in identifying high-risk behaviors?\n\nThe use of the Edinburgh criteria may lead to the discarding of safe donations and could have negative consequences by reducing the perceived responsibility of staff in eliciting a history of high-risk behavior."}
{"text": "What are the most common adverse reactions experienced by blood donors during the donation process?\n\nThe most common adverse reactions experienced by blood donors include episodes and soft tissue injuries, as well as bruises and haematomas at the venepuncture site."}
{"text": "What actions should be taken if a donor experiences a minor adverse reaction during donation?\n\nIf a donor experiences a minor adverse reaction, medical care outside the British Thoracic Society (BTS) may be required, and the donor might experience prolonged symptoms or incapacity. Staff should be trained to recognize and manage such reactions, including providing first aid."}
{"text": "What should be included as part of the donor haemovigilance system according to the passage?\n\nA system for the reporting and investigation of adverse donor events and reactions."}
{"text": "What parameters may be established to define good health according to the passage?\n\nCertain associated parameters may be established from a brief medical history, observation, and simple tests."}
{"text": "What factors should be considered to determine a blood donor's suitability or need for deferral?\n\nFactors such as minor illnesses, exposure to communicable diseases, travel to disease endemic areas, pregnancy and lactation, and medical and surgical interventions should be considered."}
{"text": "What are the four broad categories of conditions that determine blood donor eligibility based on selection criteria?\n\nThe four broad categories are: 1) Conditions that are acceptable, 2) Conditions that require temporary deferral for defined periods of time, 3) Conditions that require permanent deferral, and 4) Conditions that require individual assessment."}
{"text": "At what minimum age are most countries allowing individuals to donate blood, and what conditions must be met for those under 18 to donate?\n\nMost countries set the minimum age for blood donation at 18 years. However, individuals aged 16 to 17 can donate if they meet the physical and haematological criteria and provide appropriate consent."}
{"text": "At what minimum age should individuals start donating blood to ensure their health and safety, according to the provided text?\n\nThe minimum age for individuals to start donating blood to ensure their health and safety is 16 years."}
{"text": "At what minimum age is parental permission required for blood donation according to the passage?\n\nThe passage does not specify the exact minimum age for parental permission required for blood donation; it only mentions that the BTS should consider the age of legal consent below which parental permission is required."}
{"text": "Why have upper age limits for blood donation been set between 60 and 70 years?\n\nUpper age limits for blood donation have been set between 60 and 70 years due to concerns regarding the increasing incidence of cardiovascular disease with age and the potential risk of adverse reactions."}
{"text": "At what age is the upper limit for regular blood donors typically set, considering healthy life expectancy?\n\nThe upper age limit for regular blood donors is typically set at 60 years, although this can vary depending on the country's healthy life expectancy."}
{"text": "At what age can first-time blood donors make their donation if they are older than 60 years?\n\nFirst-time blood donors older than 60 years should make their first donation at a donation site where a physician is available."}
{"text": "Should a prospective blood donor have a normal skin color without signs of jaundice, cyanosis, flushing, or pallor?\n\nYes, a prospective blood donor should have normal skin color without signs of jaundice, cyanosis, flushing, or pallor."}
{"text": "What factors should be considered to assess the risk of transfusion-transmissible infections (TTI) during venepuncture?\n\nThe factors to consider include the presence of body piercings or tattoos, the cleanliness of the venepuncture site, the absence of skin lesions or scars, and the examination of arms for signs of injecting drug use."}
{"text": "Can donors with sight or hearing impairments donate blood at the culture site, and under what conditions?\n\nYes, donors with sight or hearing impairments can donate blood at the culture site, provided that clear and confidential communication can be established."}
{"text": "Can minor infections like common upper respiratory infections be transmitted through blood transfusion?\n\nThere is no evidence that minor infections such as common upper respiratory infections can be transmitted by transfusion, but it is advisable as a precautionary measure."}
{"text": "For how long should individuals with a recent infection defer blood donation after full recovery and cessation of therapy?\n\nIndividuals should defer blood donation for 14 days following full recovery and cessation of any therapy, including antibiotics."}
{"text": "What is the maximum volume of blood a donor can give according to the guidelines provided?\n\nThe maximum volume of blood a donor can give, as per the guidelines, should not exceed 13 units of their own blood volume."}
{"text": "What is the maximum volume of extracorporeal blood that should be collected from a donor during apheresis procedures?\n\nThe maximum extracorporeal blood volume that should be collected from a donor during apheresis procedures is not to exceed 15% of the donor's total blood volume at any stage of the procedure."}
{"text": "What is the minimum weight requirement for plateletpheresis and plasmapheresis donors?\n\nDonors should weigh at least 50 kg."}
{"text": "What is the minimum weight requirement for a prospective donor to donate 350 ml of whole blood?\n\nA prospective donor should weigh at least 45 kg to donate 350 ml of whole blood."}
{"text": "What is the normal range for a pulse rate and rhythm that indicates good health according to many BTS recommendations?\n\nA normal pulse rate ranges from 60 to 100 beats per minute, with a regular rhythm."}
{"text": "At what core oral temperature is a donor considered febrile and therefore unwell for the purpose of donation?\n\nA donor is considered febrile and unwell for donation if their core oral temperature is more than 37.8\u00b0C."}
{"text": "What is the upper limit of BP for blood donors set by lection and BTS, and why?\n\nThe upper limit of BP for blood donors set by lection and BTS is 70. This limit is established because uncontrolled hypertension is considered an independent risk factor for cardiovascular disease."}
{"text": "Why is accurate blood pressure measurement important during blood donation?\n\nAccurate blood pressure measurement is important during blood donation because it requires calibrated equipment, suitable facilities, adequate time, and appropriately skilled staff to ensure the health and safety of the donor."}
{"text": "What are the suggested systolic and diastolic blood pressure limits for blood donation selection criteria?\n\nThe suggested systolic blood pressure limit is between 100 to 140 mmHg, and the diastolic blood pressure limit is between 60 to 90 mmHg."}
{"text": "What are the commonly recommended minimum haemoglobin levels for females and males according to international and national guidelines?\n\nThe commonly recommended minimum haemoglobin levels are 120 g/dL for females and 130 g/dL for males."}
{"text": "What are the WHO Global Database on Anaemia's defined haemoglobin thresholds for anaemia in nonpregnant women and men?\n\nThe WHO Global Database on Anaemia defines haemoglobin thresholds for anaemia as 12.0 g/dL for nonpregnant women and 13.0 g/dL for men."}
{"text": "Why is it important to screen anaemic individuals before allowing them to donate blood?\n\nScreening anaemic individuals is crucial to safeguard them from donating blood and to protect returning donors from donation-induced iron deficiency, ensuring the health and safety of both donors and recipients."}
{"text": "Why are traditional methods of assessing iron deficiency considered insufficient?\n\nTraditional methods are deemed insufficient because they only indicate iron deficiency when iron stores are already significantly depleted."}
{"text": "At what haemoglobin level should a potential blood donor be referred for further investigation and treatment if they do not meet the minimum requirements?\n\nA potential blood donor should be referred for further haematological investigation and treatment if they do not meet the minimum haemoglobin levels for blood donation."}
{"text": "What is the minimum haemoglobin level threshold for females in the local population according to the provided text?\n\nThe minimum haemoglobin level threshold for females in the local population is not less than 12.0 g/dL."}
{"text": "Why is it important for individuals, especially women of childbearing age and adolescents, to undergo medical assessment before donating blood?\n\nIt is important because donation-induced iron deficiency is a particular concern for these groups, and they are also at risk of iron deficiency during periods of rapid growth, such as puberty."}
{"text": "How much haem iron is removed from the nation's blood during the process described in the passage?\n\n200 mg of haem iron is removed from the nation's blood."}
{"text": "How often can female donors typically give blood in a year due to iron deficiency?\n\nFemale donors are usually unable to give blood more than once or twice per year due to iron deficiency."}
{"text": "Why is universal screening and deferral of blood donors with low hemoglobin levels important?\n\nUniversal screening and deferral of blood donors with low hemoglobin levels are important to detect and manage donation-induced iron depletion that inevitably accompanies regular blood donation."}
{"text": "How does RDW blood cell distribution width perform in healthy donors from populations with low prevalence of inherited conditions for DIID onset detection?\n\nRDW blood cell distribution width, along with more sophisticated red cell parameters, can serve as better indicators of DIID onset in healthy donors from such populations, even in the presence of thalassaemia trait. However, these advanced parameters are costlier and typically not available at blood donation sites."}
{"text": "Why is regular ferritin measurement considered useful in the context of blood donation?\n\nRegular ferritin measurement is useful as it serves as an indicator for iron depletion in blood donors."}
{"text": "Why has iron supplementation been proposed for blood donors, and what considerations are there for its implementation?\n\nIron supplementation of blood donors has been proposed for routine implementation to replenish donor iron stores, especially for repeat and regular donors. This is particularly important as their iron stores may deplete over time. However, indiscriminate long-term supplementation with high doses of iron salts is not recommended due to the potential risk of masking other pathological causes of iron deficiency."}
{"text": "What are the risks associated with giving iron salts to individuals with undiagnosed hereditary haemochromatosis?\n\nThe risks include potential toxicity and exacerbation of the condition due to undiagnosed hereditary haemochromatosis or other inherited iron overloading tendencies."}
{"text": "What is the recommended interval between whole blood donations and apheresis platelet or plasma donations?\n\nThe recommended interval is at least 4 weeks."}
{"text": "What is the minimum interval between whole blood donations for males and females?\n\nThe minimum interval should be 12 weeks for males and 16 weeks for females."}
{"text": "How should the frequency of red cell donation and the need for iron supplementation be determined according to the BTS?\n\nThe frequency of red cell donation and the need for iron supplementation should be determined by considering the donor's age, whether they are young or of childbearing age, and the feasibility and affordability of providing iron supplementation to donors susceptible to donation-induced iron depletion."}
{"text": "What are the recommended guidelines for donors' food and fluid intake before donation according to the passage?\n\nDonors should maintain their usual food and fluid intake before donation, avoiding heavy or fatty meals."}
{"text": "How much drinking water intake before donation may reduce the risk of a vasovagal reaction?\n\nAn intake of 500 ml of drinking water immediately before donation may reduce the risk of a vasovagal reaction."}
{"text": "Why should female donors be deferred from donating blood during pregnancy and for a certain period after delivery or following abortion or miscarriage?\n\nFemale donors should be deferred during pregnancy and for a sufficient time after delivery or following abortion or miscarriage to allow for the recovery of iron stores, as they need about 350-545 mg additional iron to maintain iron balance during pregnancy."}
{"text": "Why should female donors with low haemoglobin levels due to excessive menstrual bleeding not donate blood?\n\nFemale donors with low haemoglobin levels due to excessive menstrual bleeding should not donate blood because they are at risk and should be referred for medical assessment."}
{"text": "What is the minimum haemoglobin level required for female blood donors who are pregnant or within 6 months post-pregnancy?\n\nThe passage does not specify the minimum haemoglobin level required for female blood donors who are pregnant or within 6 months post-pregnancy."}
{"text": "What are the types of antibodies that can be alloimmunereactive and potentially harmful during transfusion?\n\nThe alloimmunereactive antibodies include those to human leucocyte antigens (HLA) or human neutrophil antigens (HNA), which can be transferred passively during transfusion and may cause harm to recipients with the corresponding antigen."}
{"text": "How long should donors in hazardous occupations wait before resuming work after donating blood?\n\nDonors in hazardous occupations should wait at least 24 hours before resuming work after donating blood."}
{"text": "What are the general guidelines for donors regarding physical activities after blood donation?\n\nDonors are generally advised not to undertake strenuous physical activities for up to 24 hours after blood donation."}
{"text": "What specific occupations should be questioned about possible exposure risk when selecting blood donors?\n\nDonors in occupations where they may have been exposed to risks such as blood splashes, bites should be questioned about possible exposure risk."}
{"text": "What are the components that can be donated through apheresis?\n\nThe components that can be donated through apheresis include platelets, plasma, leucocytes, and red blood cells."}
{"text": "What specific requirements should apheresis platelet donors meet according to the guidelines?\n\nApheresis platelet donors should have a platelet count that meets the specific requirements outlined in the guidelines."}
{"text": "What is the minimum total protein level required for a donor to be eligible for plasma donation through apheresis?\n\nThe donor's total protein level should be greater than 60 g/L."}
{"text": "Why might a donor with a haematological disorder be deferred from donating blood?\n\nA donor with a haematological disorder might be deferred to avoid risks such as anaemia, bruising and haematoma, or thrombosis that could result from the venepuncture."}
{"text": "Why are individuals with certain conditions not suitable to donate blood according to the passage?\n\nIndividuals with specific conditions, including those with malignant diseases, blood transfusion and transplantation-related issues, haematinic iron deficiency, B deficiency, folate deficiency, and unidentified anaemia, are deemed unsuitable to donate blood as per the information provided in the passage."}
{"text": "What are the conditions under which individuals with a past history of iron deficiency anaemia can be recommended for blood donation?\n\nIndividuals with a past history of iron deficiency anaemia can be recommended for blood donation if they have a known cause that is not a contraindication to donation, have completed treatment, and are fully recovered."}
{"text": "Are individuals with thalassaemia major and sickle cell disease considered suitable for blood donation?\n\nNo, individuals with thalassaemia major and sickle cell disease are not suitable as blood donors."}
{"text": "Can individuals with sickle cell trait donate blood for leucodepletion?\n\nNo, most BTS do not accept donors with sickle cell trait for apheresis donations or for whole blood donations if the blood is to be leucofiltered."}
{"text": "What is the minimum haemoglobin level requirement for individuals with sickle cell trait to donate blood by whole blood donation?\n\nThe passage does not specify the exact minimum haemoglobin level requirement for individuals with sickle cell trait to donate blood by whole blood donation. It only states that they must meet the minimum haemoglobin level for blood donation."}
{"text": "Why is blood from individuals with G6PD deficiency unsuitable for transfusion?\n\nBlood from individuals with G6PD deficiency is unsuitable for transfusion because haemolysis may be precipitated in these individuals, especially if they have a history of haemolysis."}
{"text": "What conditions may prevent a person from donating red blood cells due to anemia?\n\nA person may be too anemic to donate red blood cells if they have pyruvate kinase deficiency or inherited red cell membrane disorders caused by mutations in various membrane or skeletal proteins."}
{"text": "What are the recommended policies for the assessment of prospective blood donors in regions with high incidences of enzymopathies and inherited red cell membrane defects?\n\nThe recommended policies are for the Blood Transfusion Service (BTS) to develop assessment guidelines for prospective donors in such regions. These guidelines should consider the presence of enzymopathies and inherited red cell membrane defects."}
{"text": "Why are individuals with thrombocytopenia not accepted as blood donors?\n\nIndividuals with thrombocytopenia are not accepted as blood donors due to the risk of bleeding at the venepuncture site and the possibility that chronic thrombocytopenia may be linked to serious underlying haematological or other systemic diseases."}
{"text": "After how many years of being well can individuals with a past history of acute autoimmune thrombocytopenia donate blood if they no longer require treatment?\n\nIndividuals with a past history of acute autoimmune thrombocytopenia more than 5 years previously can donate blood if they are well and no longer require treatment."}
{"text": "Can individuals with secondary erythrocytosis from smoking be accepted as blood donors under certain conditions?\n\nYes, they can be accepted as blood donors if polycythaemia rubra vera is excluded and other donor selection criteria are met."}
{"text": "What conditions allow individuals to be accepted as blood donors aside from the general criteria?\n\nIndividuals with hereditary haemochromatosis can be accepted as blood donors if they fulfill all other donor selection criteria."}
{"text": "Why are patients with inherited coagulation disorders generally not accepted as blood donors?\n\nPatients with inherited coagulation disorders are not accepted as blood donors because of the risk of excessive bruising at venepuncture sites and the fact that their treatment typically involves blood products."}
{"text": "Do individuals with carrier states for inherited coagulation disorders who have normal coagulation factor levels and no history of abnormal bleeding require treatment with blood products permanently?\n\nNo, individuals with carrier states for inherited coagulation disorders who have normal or near normal coagulation factor levels, do not have a history of abnormal bleeding, and have not received treatment with blood products permanently do not require treatment with blood products permanently."}
{"text": "Can patients with cardiovascular disease safely donate blood according to observational studies in the United States?\n\nYes, patients with cardiovascular disease can safely donate blood, but the studies were mostly applicable to preoperative autologous blood donation in a hospital setting."}
{"text": "Can individuals with a history of myocardial infarction or treated ischaemic heart disease be accepted as voluntary donors?\n\nYes, but only if they have been asymptomatic for 52 months previously, have been successfully treated for ischaemic heart disease by angioplasty or coronary artery bypass grafting, and the circumstances are exceptional with well-monitored donations."}
{"text": "Can individuals with surgically corrected simple congenital cardiac malformations without residual symptoms donate blood?\n\nYes, individuals with surgically corrected simple congenital cardiac malformations who have no residual symptoms can donate blood."}
{"text": "Is there a link between blood pressure conditions and adverse reactions to blood donation?\n\nThere is no evidence that raised baseline blood pressure, treated hypertension, or low blood pressure are predictive of increased adverse reactions to blood donation."}
{"text": "Can individuals with well-controlled blood pressure on medication donate blood?\n\nYes, individuals whose blood pressure is well-controlled by medication and meet other donor selection criteria can be accepted as blood donors."}
{"text": "After stabilizing blood pressure on antihypertensive medication, for how long should individuals defer taking any new medication or having their dose adjusted?\n\nIndividuals should defer for 28 days after their blood pressure has been stabilized permanently."}
{"text": "What condition may be associated with recurrent thrombophlebitis and what is the recommended action for individuals identified with a thrombophilic condition but without a history of thrombotic episodes?\n\nRecurrent thrombophlebitis may be associated with occult malignancy. For individuals identified with a thrombophilic condition but without a history of thrombotic episodes and not on anticoagulant treatment, it is recommended to have had a single episode of deep vein th"}
{"text": "Under what conditions can individuals be considered for the mentioned criteria based on their history of thrombophlebitis?\n\nIndividuals can be considered for the mentioned criteria if they have had a single episode of thrombophlebitis in the last 12 months, provided they are fully recovered and off anticoagulant therapy for at least 7 days. Additionally, those who have had two or more episodes of venous thrombosis requiring treatment, axillary vein throm"}
{"text": "Under what conditions should individuals with asthma be considered for organ donation?\n\nIndividuals with asthma can be considered for organ donation if they are asymptomatic on a maintained dose of nonsteroid or inhaled steroid medication."}
{"text": "After recovering from acute respiratory infections, how long should individuals defer activities before they can resume them?\n\nIndividuals should defer activities for 14 days following full recovery and cessation of any therapy, including antibiotics."}
{"text": "Which conditions are considered suitable for individuals with diseases of the gastrointestinal tract according to the recommendations?\n\nIndividuals with Irritable bowel syndrome without debility, Diverticular disease if well, Mild gastroesophageal reflux, Mild hiatus hernia, Treated coeliac disease, Gallstones when fully recovered, and Cholecystitis when fully recovered."}
{"text": "Can individuals with well-managed ulcerative colitis or Crohn's disease donate blood if they meet specific criteria?\n\nYes, individuals with well-managed ulcerative colitis or Crohn's disease can donate blood if they are in long-term remission and meet the minimum haemoglobin levels for blood donation."}
{"text": "Is diabetes mellitus considered a risk factor for adverse reactions in voluntary blood donors?\n\nNo, there are no reports suggesting increased adverse donor reactions in diabetic donors, and a systematic literature review found no studies investigating diabetes as a risk factor for adverse reactions in voluntary blood donors."}
{"text": "What are the findings regarding blood donation in individuals with diabetes who require insulin?\n\nIndividuals with diabetes who require insulin should be permanently deferred from blood donation due to concerns about diabetes-related complications and an increased risk of infections if safe injection practices cannot be assured."}
{"text": "Are individuals with a history of thyroid disease at risk of adverse effects from blood donation?\n\nNo, there is no published evidence about any adverse effects from blood donation to individuals with a history of thyroid disease."}
{"text": "Should individuals with benign thyroid disorders who are euthyroid be considered for recommendations?\n\nYes, individuals with benign thyroid disorders who are euthyroid should be considered for recommendations."}
{"text": "Can individuals with systemic immunological diseases donate blood?\n\nNo, individuals with systemic immunological diseases are generally unwell and are not suitable to donate blood."}
{"text": "Should individuals with a history of anaphylaxis be permanently deferred from donating blood?\n\nYes, individuals with a history of anaphylaxis are recommended to be permanently deferred from donating blood as a precautionary measure."}
{"text": "Which autoimmune disorders mentioned in the passage may lead to the need for immunosuppression?\n\nSystemic lupus erythematosus, dermatomyositis, and severe rheumatoid disease."}
{"text": "After recovering from which conditions should individuals consider deferral, and for how long?\n\nIndividuals with lower urinary tract infections should defer for 14 days after full recovery and completion of treatment. Those with acute self-limiting renal diseases like acute nephritis should consider a deferral for as long as 5 years after full recovery when renal functions are normal. Individuals with chronic renal disease causing ill-health, anaemia, or a need for permanent deferral should also consider"}
{"text": "What factors should be considered when assessing the suitability of prospective donors with central nervous system conditions for blood donation?\n\nThe assessment should consider the wellbeing of the donor and the risk of transmitting variant Creutzfeldt-Jakob disease through transfusion. Additionally, the potential impact of cerebrovascular disease and associated blood pressure changes, particularly during sleep after donation, should be taken into account."}
{"text": "Should individuals with a history of transient cerebral ischemic episodes or completed stroke be permanently deferred from donating blood?\n\nYes, individuals with a history of transient cerebral ischemic episodes or completed stroke should be permanently deferred from donating blood."}
{"text": "Why should individuals with dementia or neurodegenerative diseases be permanently deferred from receiving medication transfusions?\n\nIndividuals with dementia or neurodegenerative diseases should be permanently deferred due to their inability to provide a reliable medical history and the potential risks associated with their condition."}
{"text": "For which conditions should individuals be permanently deferred according to the recommendations?\n\nIndividuals with multiple sclerosis, a history of epilepsy who have been seizure-free for at least 3 years, cerebrovascular disease with a history of transient cerebral ischaemic episodes or stroke, dementia or neurodegenerative disease due to any cause, multiple sclerosis or other demyelinating diseases."}
{"text": "What is the range of time for which some BTS accept donors who have been disease-free after being treated for solid tumors?\n\nSome BTS accept donors who are disease-free for a specified period ranging from 128 to 138 months."}
{"text": "Did recipients of blood from precancerous donors show an increased risk of developing cancer compared to those who received blood from noncancerous donors within five years of the donation?\n\nNo, recipients of blood from precancerous donors did not show an increased risk of developing cancer compared to those who received blood from noncancerous donors within five years of the donation."}
{"text": "Should individuals with a history of malignant diseases, excluding basal cell carcinoma or cervical carcinoma in situ, be considered for blood donation?\n\nYes, individuals with a history of malignant diseases, except for basal cell carcinoma or cervical carcinoma in situ, should be considered for blood donation as there is ample evidence to support this, provided there are no specific safety concerns."}
{"text": "After how many years of successful curative treatment can a healthy adult with a history of treated malignant conditions donate?\n\nA healthy adult with a remote history of treated malignant conditions can donate after a minimum suggested 5-year interval following the completion of successful curative treatment."}
{"text": "Can individuals with a history of in situ malignant diseases like basal cell carcinoma or cervical carcinoma in situ, who are regularly monitored and deemed successfully treated and in good health, receive the treatment mentioned in the passage?\n\nYes, such individuals can receive the treatment as they are considered successfully treated and in good health."}
{"text": "Can individuals with acute or chronic simple musculoskeletal disorders like back pain and osteoarthritis climb on and off a donation couch without assistance if it does not hinder their daily activities?\n\nYes, individuals with such disorders can climb on and off a donation couch without assistance as long as it does not inhibit their daily routine activities."}
{"text": "Should the assessment of prospective donors with skin diseases take into account the use of prescribed medications like antibiotics or immunosuppressants?\n\nYes, the assessment should consider whether the donor is receiving prescribed medications such as antibiotics, anti-inflammatory agents, immunosuppressants, or vitamin A analogues."}
{"text": "Can individuals with mild eczema, mild acne, or mild psoriasis without infected lesions or systemic symptoms donate blood?\n\nYes, individuals with mild eczema, mild acne, or mild psoriasis provided they do not have infected lesions, systemic symptoms, an affected venepuncture site, or are receiving immunosuppressive or retinoid treatment long-term, can donate blood."}
{"text": "Are individuals with systemic diseases affecting the skin, such as Scleroderma, eligible to donate blood?\n\nYes, individuals with systemic diseases affecting the skin, such as Scleroderma, are considered for blood donation."}
{"text": "Can individuals with anxiety disorders and mood affective disorders donate blood?\n\nYes, they can donate provided they are stable and feel well on the day, regardless of medication."}
{"text": "Can individuals with anxiety disorders or mood affective disorders, such as depression or bipolar disorder, donate blood if they are in good health and not displaying obvious symptoms on the day of donation?\n\nYes, individuals with anxiety disorders or mood affective disorders can donate blood if they are generally in good health and not obviously overanxious, depressed, or manic on the day of donation, regardless of their medication."}
{"text": "Why should vaccinations and postexposure prophylaxis considerations be made in blood donations?\n\nVaccinations and postexposure prophylaxis considerations should be made in blood donations because the intervention could affect the quality or safety of the blood and blood products, and patient safety."}
{"text": "Can individuals who have received nonlive vaccines and toxoids, except for the HBV vaccine, and have no history or known exposure to infection, donate blood?\n\nYes, such individuals may be accepted as blood donors provided they are well."}
{"text": "After receiving routine vaccination for hepatitis B, for how long should individuals with no known exposure to the virus defer from donating blood?\n\nIndividuals should defer for 14 days after receiving routine vaccination for hepatitis B before donating blood."}
{"text": "Are there any published cases of adverse effects in patients receiving transfusions from donated blood with medications, according to the provided text?\n\nThere is no published evidence that medications in donated blood have caused adverse effects in a patient receiving a transfusion."}
{"text": "What can happen to the plasma concentration of donor medications when more than 50 ml plasma is transfused to a recipient?\n\nThe plasma concentration of donor medications may exceed 10 times the therapeutic level."}
{"text": "Why should donations from individuals who have taken aspirin or NSAIDs within certain time frames not be used for preparing platelet components?\n\nDonations from individuals who have taken aspirin within 5 days or NSAIDs within 48 hours should not be used for platelet components because these medications irreversibly inhibit platelet aggregation."}
{"text": "Can transfusing blood containing etretinate, acitretin, or isotretinoin to a pregnant woman in her first trimester cause fetal abnormalities?\n\nYes, it can cause fetal abnormalities."}
{"text": "After completing treatment for acute infections with antibiotics, for how many days should individuals defer taking other medications?\n\nIndividuals should defer taking other medications for 14 days after completing treatment for acute infections with antibiotics."}
{"text": "Why should individuals who have received a blood transfusion not donate blood for 12 months?\n\nIndividuals who have received a blood transfusion should not donate blood for 12 months because it remains an important risk factor for transfusion-transmitted infections, including iatrogenic Creutzfeldt-Jakob disease."}
{"text": "After how many months should individuals who have received a blood transfusion defer from sexual contact?\n\nIndividuals who have received a blood transfusion should defer from sexual contact for 12 months."}
{"text": "Why should individuals on regular treatment with plasma-derived coagulation factors not be accepted as blood donors?\n\nIndividuals on regular treatment with plasma-derived coagulation factors should not be accepted as blood donors because such treatment indicates serious underlying disease, and these patients should not be accepted as blood donors."}
{"text": "Should recipients of corneal transplants in countries with identified risk be permanently deferred from blood donation?\n\nYes, recipients of corneal transplants in such countries should be permanently deferred as a precaution against possible transmission of iatrogenic CJD."}
{"text": "Why should individuals awaiting a surgical procedure likely to result in blood loss be temporarily deferred?\n\nTo prevent compromising their iron stores pre-operatively."}
{"text": "What are the purposes of routine donation testing for blood transfusions?\n\nRoutine donation testing for blood transfusions is performed to ensure the elimination of bacterial infections from the donated blood and to detect any transfusion-transmissible viral infections."}
{"text": "After undergoing minor diagnostic procedures, when should individuals resume normal activity before proceeding with further dental treatments?\n\nIndividuals should resume normal activity after minor diagnostic procedures before proceeding with further dental treatments."}
{"text": "For how many days following endodontic procedures should one be cautious of potential bloodborne infections if not using sterile techniques?\n\nUp to 7 days following endodontic procedures."}
{"text": "How can the microbiological safety of blood donations be compromised according to the passage?\n\nThe microbiological safety of blood donations can be compromised through donors' exposure to HIV, hepatitis B, hepatitis C, syphilis, and other transfusion-transmissible infections via sexual contact, percutaneous exposure through high-risk sexual behaviors, and unsafe blood transfusion and injection."}
{"text": "What factors should the BTS consider when establishing donor selection criteria to minimize the risk of infection transmission?\n\nThe BTS should consider the potential risks of infections present in the donor population, the prevalence, incidence, and epidemiology of transfusion-transmissible infections (TTI), and up-to-date information on known and emerging infections, including expert advice."}
{"text": "What measures should be taken when there is a proven risk of transfusion-associated transmission but no screening assays are available?\n\nDonor selection criteria should be developed to identify and defer potentially infected donors for an appropriate period of time."}
{"text": "What measures should be taken to manage donor selection criteria in the absence of appropriate screening assays for infectious diseases?\n\nIn such cases, donor selection criteria should be developed to identify and defer potentially infected donors for a suitable period. Additionally, procedures should be established for the regular review and reevaluation of these criteria in response to emerging infectious diseases, new or altered risks, cultural practices, and data from haemovigilance and other surveillance sources."}
{"text": "Why is the collaboration between various entities like blood services, public health institutions, and regulatory agencies important for the control of transfusion-transmissible infections (TTIs)?\n\nThe collaboration is important for the recognition and control of known and emerging TTIs because it facilitates knowledge sharing and implementation of measures such as active surveillance, donor selection criteria, screening of donations, and monitoring of transfusions."}
{"text": "Which document provides information on the prevalence and epidemiology of transfusion-transmissible infections?\n\nThe WHO Global Health Atlas"}
{"text": "How long is the incubation period before clinical signs and symptoms appear in transfusion-transmitted infections?\n\nThe incubation period is generally long before the appearance of clinical signs and symptoms."}
{"text": "Why can't the screening process for blood component release be considered totally effective?\n\nThe screening process cannot be considered totally effective because infections in donated blood may not be detected due to the collection of the donation during the window period of infection, assay sensitivity issues, or errors. Additionally, there are some emerging infections for which screening is not available or effective."}
{"text": "Why is routine screening for certain transfusion-transmissible infections (TTIs) like hepatitis A virus or parvovirus B19 not considered practical or cost-effective?\n\nRoutine screening for these infections is not practical or cost-effective because the screening tests available may not be suitable for blood screening purposes and are often designed to assist in diagnosing infections rather than screening blood donations."}
{"text": "Why is donor selection a significant factor in the identification and deferral of donors in the context of preventing infections in the blood supply?\n\nDonor selection is significant because it helps to reduce the risk of infections entering the blood supply by deferring individuals or groups who might harbor these infections."}
{"text": "Why is understanding the timing of infection important in the donor selection process?\n\nUnderstanding the timing of infection is important in the donor selection process because it helps determine the length of the window period, which is the time between infectivity and the first detection of a defined marker of infection, and the incubation period, which is the time between exposure to infection and the onset of any symptoms of illness. This knowledge is crucial to ensure the safety of blood transfusions."}
{"text": "Why is it important for the selection process to identify and defer individuals who pose a threat to blood safety?\n\nIt is important to identify and defer such individuals to prevent the collection of infectious donations, especially when infections are more likely to be symptomatic and could potentially harm recipients."}
{"text": "Why are individuals with high-risk behaviors for HIV, HBV, and HCV infection deferred from being accepted as blood donors?\n\nIndividuals with high-risk behaviors for HIV, HBV, and HCV infection are deferred from being accepted as blood donors to prevent the potential exposure to these infections through the donation process."}
{"text": "How should the BTS reconcile the approach to donor risk exposure with their duty to treat donors and prospective donors?\n\nThe BTS should reconcile the approach by ensuring that the knowledge of risks to donors is balanced with the duty to treat donors and prospective donors with respect, compassion, and dignity, while avoiding any form of discrimination."}
{"text": "Under what circumstances should a donor be deferred from donating blood?\n\nA donor should be deferred from donating blood if they have been diagnosed with an infection or have been in close contact with an infectious disease, especially during the incubation period of the infection."}
{"text": "What factors determine the deferral periods for specific infections in the context of blood donation?\n\nThe deferral periods for specific infections in blood donation are determined by the type of infection, the appropriate deferral periods for those infections as provided by health organizations like WHO, and the travel or residence history of the donor in regions where certain infections are endemic. Additionally, deferral criteria may be extended if donors have had any undiagnosed febrile illness during travel or since the last donation."}
{"text": "For which sections of the provided text are deferral periods for individuals traveling to endemic regions specified?\n\nDeferral periods are specified in Section  for viral infections and Section  for protozoal infections."}
{"text": "Why should prospective blood donors be asked about their history of jaundice or hepatitis?\n\nProspective blood donors should be asked about their history of jaundice or hepatitis to determine if they have been further investigated to identify the cause, as this information is crucial to assess their eligibility to donate blood due to the risk of hepatitis transmission."}
{"text": "Under what conditions might individuals with a history of jaundice or hepatitis be considered as organ donors?\n\nIndividuals with a history of jaundice or hepatitis might be considered as organ donors if, at the physician's discretion, their test results are satisfactory."}
{"text": "How long does the average period of the hepatitis B virus last, and what is the range of this duration?\n\nThe average period of the hepatitis B virus lasts about 90 days, with a range that can vary from 30 to 180 days."}
{"text": "What is the recommended deferral period for individuals with confirmed HBV infection before they can donate blood?\n\nThe recommended deferral period is 12 months from recovery."}
{"text": "Under what conditions can individuals with a past history of HBV donate blood?\n\nIndividuals with a past history of HBV can donate blood if more than 12 months have passed since their infection."}
{"text": "Who should be established and followed up with reentry procedures according to the passage?\n\nIndividuals with initially reactive results for HBsAg but confirmed to be nonreactive should be established and followed up with reentry procedures."}
{"text": "For how long should individuals with active HBV infection defer contact with others after their last sexual contact?\n\nIndividuals with active HBV infection should defer contact with others for 12 months since their last sexual contact."}
{"text": "How is hepatitis C most commonly transmitted?\n\nHepatitis C is most commonly transmitted through exposure to infectious blood, which can occur via contaminated blood transfusions, blood products, organ transplants, injections with contaminated syringes, healthcare settings during injecting drug use, or from a mother to her child during childbirth."}
{"text": "How long should former sexual contacts of individuals with HCV infection defer sexual activity after the last contact?\n\nFormer sexual contacts of individuals with HCV infection should defer for 12 months after the last sexual contact."}
{"text": "How is hepatitis A primarily transmitted?\n\nHepatitis A is primarily transmitted through the fecaloral route."}
{"text": "How long is the usual period of hepatitis A?\n\nThe usual period of hepatitis A is 1428 days."}
{"text": "On what basis is the diagnosis of hepatitis E infection usually made?\n\nThe diagnosis of hepatitis E infection is usually made based on the detection of specific antibodies to the virus in the blood."}
{"text": "For how long should sexual contacts, household members, and close contacts of individuals with HAV, HEV, or hepatitis of unknown origin defer from their activities after full recovery?\n\nThey should defer for 12 months after full recovery."}
{"text": "What are some examples of behaviors that can increase the risk of contracting HIV?\n\nExamples of behaviors that can increase the risk of contracting HIV include kissing, hugging, shaking hands, or sharing personal objects, food, or water. Additionally, engaging in unprotected anal or vaginal sex, having another sexually transmitted infection, sharing contaminated needles or equipment, and receiving unsafe injections are also high-risk behaviors."}
{"text": "What are the estimated infectivity rates for HIV transmission through transfusion of infected blood products compared to other modes of transmission?\n\nThe estimated infectivity rates for HIV transmission through transfusion of infected blood products are much higher, around 95%, compared to other modes of transmission."}
{"text": "For how long should individuals with HIV infection defer sexual contact after their last sexual encounter?\n\nIndividuals with HIV infection should defer sexual contact for 12 months since their last sexual contact."}
{"text": "Who should be screened for HTLV I and II infection according to the recommendations?\n\nIndividuals whose mother or maternal grandmother has or had HTLV I and II infection, former sexual contacts of individuals with HTLV I and II infection, and household contacts of individuals with HTLV I and II infection should be screened for HTLV I and II infection."}
{"text": "After how many months should current sexual contacts of individuals with HTLV I and II infection defer sexual activity, and what is the condition for former sexual contacts regarding this deferral period?\n\nCurrent sexual contacts should defer for 12 months after the last sexual contact, and former sexual contacts should permanently defer for 12 months after their last sexual contact."}
{"text": "Why should symptomatic donors be deferred until fully recovered in the context of blood screening for HTLV I and II infections?\n\nSymptomatic donors should be deferred until fully recovered because all the mentioned herpes viruses, including HTLV I and II, can give rise to latent infections and some are transfusion-transmissible, posing a risk if the donor is not fully recovered."}
{"text": "For which virus is the exclusion of donors with a history of past infection considered neither feasible nor useful, except in the case of HHV8?\n\nHHV8"}
{"text": "For how long should individuals who are symptomatic except for HHV8 infection defer from certain activities?\n\nThey should defer for 28 days."}
{"text": "What is the primary method to prevent transfusion-transmission of WNV in endemic areas?\n\nBlood screening using molecular technology is the primary method to prevent transfusion-transmission of WNV in endemic areas."}
{"text": "After visiting an endemic area, for how long is the deferral period for donating blood in some countries, and under what conditions is it extended?\n\nThe deferral period is 28 days after visiting an endemic area, and it is extended to 6 months from full recovery if the donor has had any symptoms suggestive of West Nile Virus (WNV)."}
{"text": "Can both chikungunya and dengue cause chronic infections?\n\nNo, both chikungunya and dengue cause acute infections and do not lead to chronic infections."}
{"text": "In which regions are Southeast Asia and the Western Pacific most affected by Chikungunya?\n\nSoutheast Asia and the Western Pacific are the most affected regions by Chikungunya."}
{"text": "How long should individuals with a history of dengue or chikungunya virus defer traveling to endemic areas after full recovery?\n\nIndividuals should defer traveling to endemic areas for 6 months after full recovery from dengue or chikungunya virus infection."}
{"text": "For how long should individuals with measles, rubella, mumps, or chickenpox defer donation after full recovery?\n\nIndividuals should defer donation for 14 days after full recovery."}
{"text": "After how many days of full recovery should individuals with an active influenza infection be deferred from donating blood?\n\nIndividuals with an active influenza infection should be deferred for 14 days after full recovery."}
{"text": "For how many days should symptomatic individuals with an active infection defer from donating after full recovery and cessation of any therapy?\n\nSymptomatic individuals with an active infection should defer for 14 days after full recovery and cessation of any therapy."}
{"text": "After receiving a vaccination, for how long should a donor defer plasma donation, and under what condition should this period be extended?\n\nA donor should defer plasma donation for 48 hours after vaccination. This deferral period should be extended if the donor is in a specific risk category for protozoal infections."}
{"text": "Which species of Plasmodium is considered the most deadly and causes the majority of malaria cases in humans?\n\nP. falciparum is considered the most deadly and causes the majority of malaria cases in humans."}
{"text": "How is malaria transmitted to humans?\n\nMalaria is transmitted to humans through the bite of the female Anopheles mosquito and can also be transmitted by blood transfusion using donations from asymptomatic, parasitaemic donors."}
{"text": "How long can the parasites remain stable in plasma and whole blood when stored at 4\u00b0C?\n\nThe parasites can remain stable in plasma and whole blood for at least 18 days when stored at 4\u00b0C."}
{"text": "In nonendemic areas, what strategy should be used to screen all donations for malaria?\n\nIn nonendemic areas, all donations should be screened for malaria by using either thick blood films or a highly sensitive enzyme immunoassay to detect parasitaemia or evidence of malarial antigen."}
{"text": "Why is the BTS developing donor selection criteria in endemic areas?\n\nThe BTS is developing donor selection criteria in endemic areas to identify and collect blood from donors at the lowest risk of infection."}
{"text": "How should blood donations be screened for malaria according to the provided passage?\n\nBlood donations should be screened for parasitaemia using thick blood films smear microscopy or for evidence of malarial antigen using a highly sensitive enzyme immunoassay."}
{"text": "What strategies are implemented to identify potential malaria transmission risks in blood donors?\n\nDonor selection and deferral strategies are implemented, which include identifying individuals with a recent history of malaria or specific exposure risks like travel to malarious areas."}
{"text": "After visiting a malaria-endemic area, for how long should individuals with undiagnosed febrile illnesses defer from traveling to another malaria-endemic area if they have not been diagnosed with malaria?\n\nIndividuals with undiagnosed febrile illnesses should defer for 12 months from their last return from a malarious area if they have not been diagnosed with malaria."}
{"text": "After how many years of living in an endemic area should individuals be deferred for a period before returning, and for how long should this deferral period last?\n\nIndividuals should be deferred for 5 years after their last return from a malarious area, and the deferral period should last for 5 years."}
{"text": "After how many months should a person defer for malaria screening if they have had febrile symptoms but were not diagnosed with malaria, and have returned from a malarious area?\n\nA person should defer for malaria screening for 6 months after the last return from a malarious area if they have had febrile symptoms but were not diagnosed with malaria."}
{"text": "What is the primary method of transmission for Trypanosoma cruzi to humans in Latin America?\n\nThe primary method of transmission for Trypanosoma cruzi to humans in Latin America is mainly through the faeces of triatomine bugs, also known as kissing bugs."}
{"text": "Which regions have seen an increase in the detection of the disease due to population mobility?\n\nThe regions that have seen an increase in the detection of the disease due to population mobility include the United States of America, Canada, many European countries, and some Western Pacific countries."}
{"text": "How can transfusion transmission of infection occur according to the passage?\n\nTransfusion transmission of infection can occur through blood transfusion, vertical transmission from an infected mother to her child, or organ donation."}
{"text": "In nonendemic countries, under what conditions are individuals considered to have been exposed to the risk of infection according to the provided text?\n\nIndividuals are considered exposed to the risk of infection if they, their mother, or maternal grandmother were born in South or Central America including Southern Mexico, had a blood transfusion in these areas, or lived and/or worked in rural communities in these countries for a continuous period of 28 days or more."}
{"text": "After how many months of the last exposure can individuals be accepted if they are seronegative for T. cruzi, given that sensitive antibody assays are not permanently available?\n\nIndividuals can be accepted 6 months after the last exposure if they are seronegative for T. cruzi."}
{"text": "After returning from an endemic area, for how long should individuals with an identified risk of exposure to the disease defer from accepting sensitive antibody assays for T. cruzi if they are available?\n\nIndividuals with an identified risk of exposure to the disease should defer for 6 months after their last return from an endemic area before accepting sensitive antibody assays for T. cruzi."}
{"text": "What are the common symptoms of mptomatic infection and how can it be transmitted?\n\nThe common symptoms of mptomatic infection include mild fever, diarrhoea, and in severe cases, symptoms similar to malaria. It can be transmitted through transfusion, as reported in cases 222,223, and has a reservoir of infection in small rodents."}
{"text": "What disease is transmitted by the bite of infected sandflies and has the potential for transfusion transmission, albeit rarely reported?\n\nLeishmaniasis is the disease transmitted by the bite of infected sandflies that has the potential for transfusion transmission, though it is rarely reported."}
{"text": "After how many months should individuals who have spent extended periods in endemic areas defer blood donation?\n\nIndividuals should defer blood donation for at least 12 months since their last return to an endemic area."}
{"text": "What are some techniques used in donor selection to minimize exogenous bacterial infection?\n\nTechniques include inspection of the skin at the venepuncture site, deferral of donors with skin lesions, skin cleansing, proper venepuncture technique, use of diversion pouches, leucoreduction, and following guidance on safe phlebotomy."}
{"text": "Why should most prospective donors with endogenous bacterial infections be deferred from blood donation?\n\nMost prospective donors with endogenous bacterial infections should be deferred from blood donation because they often present with symptoms like fever, rash, diarrhoea, and malaise. This deferral is part of the general health assessment to ensure the safety and quality of the blood supply."}
{"text": "Through which process can syphilis, yaws, and gonorrhoea be transmitted?\n\nSyphilis, yaws, and gonorrhoea can be transmitted through sexual contact."}
{"text": "Can T. pallidum be transmitted through fresh blood and platelets?\n\nYes, T. pallidum can be transmitted through fresh blood and platelets."}
{"text": "After how many months should individuals with gonorrhoea defer from sexual contact following the completion of treatment?\n\nIndividuals with gonorrhoea should defer from sexual contact for 12 months following the completion of treatment."}
{"text": "After completing treatment for gonorrhea, for how long should individuals defer new sexual contacts?\n\nIndividuals should defer new sexual contacts for 12 months since their last sexual contact."}
{"text": "What are the common symptoms exhibited by infected individuals with the condition mentioned in the passage?\n\nInfected individuals typically show symptoms such as rash, fever, lymphadenopathy, and may progress to chronic arthropathy or neurological involvement."}
{"text": "How is brucellosis typically transmitted and what are the implications for its chronic nature?\n\nBrucellosis is typically transmitted through animal sources and is not usually transmitted from person to person. However, transmission through transfusion has been reported in endemic regions. The infection is usually chronic, potentially lasting for many years and causing intermittent serious illness."}
{"text": "What complications can arise from red cell transfusions according to the passage?\n\nFatal posttransfusion sepsis and toxic shock in the recipient can occur as complications from red cell transfusions."}
{"text": "After recovering from symptoms suggestive of a Salmonella, Campylobacter, or Streptococcus infection, for how long should individuals defer for further activities?\n\nIndividuals should defer for 28 days following full recovery."}
{"text": "After how many days of full wound healing should individuals with recent superficial but significant wounds defer for potential staphylococcus infection?\n\nIndividuals should defer for 14 days following full wound healing."}
{"text": "After how long should individuals with rickettsial infections defer from transfusion following the completion of treatment or cessation of symptoms?\n\nIndividuals with rickettsial infections should defer from transfusion for 6 months following the completion of treatment or cessation of symptoms."}
{"text": "What are the four distinct forms of Creutzfeldt-Jakob disease (CJD)?\n\nThe four distinct forms of Creutzfeldt-Jakob disease are sporadic, genetic familial, iatrogenic, and variant."}
{"text": "What are some of the treatments that have been associated with the development of iatrogenic CJD?\n\nIatrogenic CJD has been associated with treatments involving pituitary-derived human growth hormone, human gonadotropin, s, corneal transplants, and contaminated neurosurgical instruments."}
{"text": "How can Bovine Spongiform Encephalopathy (BSE) be transmitted to humans?\n\nBovine Spongiform Encephalopathy (BSE) can be transmitted to humans through blood transfusion."}
{"text": "What measures should national authorities prepare to minimize the risk of transfusion transmission of transmissible spongiform encephalopathies through blood and blood products?\n\nNational authorities should prepare plans for measures that minimize the risk of transfusion transmission of these diseases, without compromising the adequacy of the blood supply, and should provide guidance on risk assessment."}
{"text": "How long must individuals have spent cumulatively in the UK between 1980 and the end of 1996 to be subject to a deferral by the FDA?\n\nIndividuals must have spent 3 months or more cumulatively in the UK during that period to be subject to a deferral by the FDA."}
{"text": "What should countries do to prevent the transmission of HIV/AIDS through blood transfusions according to the passage?\n\nCountries should conduct a risk assessment and risk-benefit analysis using national and international data on the epidemiology of HIV/AIDS. They should then implement appropriate risk mitigating measures. Additionally, they may consider deferring blood donors with a history of travel or residence in specified countries or areas for defined cumulative exposure periods."}
{"text": "On what basis should individuals be excluded from blood donation to reduce the risk of transmitting CJD by blood transfusion?\n\nIndividuals should be excluded based on the findings of risk assessment and risk-benefit analysis, the impact on the blood supply, and if they have a history of treatment with human-derived therapeutic products since 1980 in a country where the risk of transmission has been identified."}
{"text": "How does the country of residence and travel history of a donor affect their exposure to transmissible tissue infections (TTI)?\n\nThe country of residence and travel history of a donor affect their exposure to TTI because these factors determine whether the donor has been in areas that are nonendemic for specific infections. This is important for donor selection as travel history can reveal potential unawareness of the geographical distribution of TTI such as malaria, certain diseases, West Nile virus, and others"}
{"text": "On what basis should testing strategies for transfusion-transmissible infections (TTIs) be developed?\n\nTesting strategies for TTIs should be based on up-to-date and readily available information on the epidemiology and prevalence of known and emerging TTIs in specific geographical areas."}
{"text": "Why is it important for the BTS to identify and defer individuals at high risk of acquiring infectious diseases through blood donation?\n\nIt is important for the BTS to identify and defer individuals at high risk of acquiring infectious diseases through blood donation to prevent the transmission of HIV, HBV, and HCV, ensuring the safety of the blood supply."}
{"text": "What are considered high-risk sexual behaviors according to the passage?\n\nHigh-risk sexual behaviors include having multiple sex partners, engaging in sex for money or drugs, involving sex workers and their clients, men having sex with men, and females having sex with men."}
{"text": "What has been the criticism regarding the permanent deferral of MSM for donating blood?\n\nThe permanent deferral of MSM has been criticized as being selectively discriminatory and lacking scientific rigour."}
{"text": "What is the current default position regarding the permanent deferral of MSM in terms of risk management?\n\nThe current default position is to endorse the permanent deferral of MSM based on the principle of risk management."}
{"text": "What criteria should be established and reviewed frequently for high-risk sexual behaviors in a specific country or region?\n\nThe criteria should be determined based on the residual risk of transfusion-transmitted viral infections, considering changes in disease epidemiology, advancements in testing technologies for donations, and ongoing research."}
{"text": "For how long should individuals with high-risk sexual behavior defer their sexual contacts after their last sexual encounter?\n\nIndividuals should defer their sexual contacts for 12 months after their last sexual encounter."}
{"text": "Should prospective donors who show signs of intoxication be deferred from donating, and why?\n\nYes, prospective donors who demonstrate signs and symptoms of intoxication should be deferred because their capacity to give informed consent is likely to be impaired."}
{"text": "Can the use of intranasal cocaine be considered a risk factor for Hepatitis C Virus (HCV)?\n\nYes, the use of intranasal cocaine has been found to be a risk factor for HCV."}
{"text": "Should inmates of prisons and penal institutions be accepted as blood donors?\n\nNo, inmates of prisons and penal institutions should not be accepted as blood donors due to a higher incidence of HIV, HBV, and HCV, as well as potential undue coercion."}
{"text": "What is the recommended action for inmates seeking cosmetic treatments and rituals involving skin penetration?\n\nThese procedures should be performed under sterile conditions to prevent the risk of bloodborne infections, such as HIV, HBV, and HCV."}
{"text": "After how many months should individuals defer from invasive cosmetic procedures like acupuncture or tattoos?\n\nIndividuals should defer for a period of 12 months following the last invasive cosmetic procedure."}
{"text": "What is an autologous donor?\n\nAn autologous donor is a patient who donates their own blood to be stored and reinfused, if needed, during surgery."}
{"text": "What is a directed donation in the context of blood donation?\n\nA directed donation is a type of blood donation that is given specifically for transfusion to a named patient."}
{"text": "What is the purpose of the process of assessing the suitability of an individual to donate blood or blood components?\n\nThe purpose is to prevent the occurrence or recurrence of adverse donor reactions and events."}
{"text": "What does the term \"Men who have sex with men (MSM)\" encompass in terms of sexual behavior and cultural interpretation?\n\nThe term \"Men who have sex with men (MSM)\" encompasses the sexual behaviors of males who engage in sex with other males, irrespective of their motivations or community affiliations. It also acknowledges that the interpretation of terms like \"man\" and \"sex\" varies across different cultures, societies, and individuals, thereby covering a wide range of settings and contexts."}
{"text": "What is the primary distinction mentioned between men with nonheterosexual identities and those who are heterosexual but engage in sex with other males?\n\nThe primary distinction is between men who share a nonheterosexual identity (gay, homosexual, bisexual, etc.) and men who view themselves as heterosexual but engage in sex with other males for various reasons such as isolation, economic compensation, sexual desire, or gender scripts."}
{"text": "How is sexual activity related to the risk of HIV transmission in prisons?\n\nSexual activity in prisons is linked to a high risk of HIV transmission, especially considering factors like human rights violations and lack of access to condoms."}
{"text": "What does the precautionary principle suggest about taking action to mitigate risks to blood safety when evidence shows there are reasonable grounds for concern, even if the risk is considered small?\n\nThe precautionary principle justifies taking precautionary action to mitigate perceived risks to the safety or supply of blood if there is the best available evidence showing reasonable grounds to support this action, despite the small probability of the risk occurring."}
{"text": "What is self-deferral in the context of blood donation?\n\nSelf-deferral is the decision by a potential donor to voluntarily postpone or permanently abstain from donating blood or blood components due to health concerns, medical conditions, or the risk of exposure to pathogens."}
{"text": "What is a transfusion transmissible infection (TTI)?\n\nA transfusion transmissible infection (TTI) is an infection that has the potential to be transmitted through blood transfusion."}
{"text": "What are the recommendations for a public health approach to HIV among men who have sex with men and transgender people according to the World Health Organization in 2011?\n\nThe World Health Organization in 2011 recommended a public health approach to address HIV among men who have sex with men and transgender people, although specific recommendations are not detailed in the provided text."}
{"text": "Which organizations acknowledged the technical collaboration and financial contribution for the project mentioned in the passage?\n\nThe US Centers for Disease Control and Prevention"}
{"text": "What is the role of the National Transfusion Microbiology Reference Laboratory at the University of Sheffield?\n\nThe National Transfusion Microbiology Reference Laboratory at the University of Sheffield is headed by a Dr who is also a Consultant in Transfusion Medicine. The laboratory is part of the National Health Service Blood and Transplant in London, United Kingdom."}
{"text": "What is the role of Ms Shereen Hasan in the field of haematology?\n\nMs Shereen Hasan is a health researcher in the field of haematology, based in Switzerland."}
{"text": "Who is the Director of Medical and Donor Affairs at the Kuwait Central Blood Bank?\n\nThe Director of Medical and Donor Affairs at the Kuwait Central Blood Bank is Dr. from the provided text."}
{"text": "What is the role of the Deputy Director in the Division of Blood and Blood Products at the Ministry of Health, Labour and Welfare in Japan?\n\nThe role of the Deputy Director in the Division of Blood and Blood Products at the Ministry of Health, Labour and Welfare in Japan is to manage the National blood programme."}
{"text": "What is the role of Dr Valentina Hafner in the context of blood transfusion services?\n\nDr Valentina Hafner is the Manager of Health Care Quality in the Division of Health Systems and Public Health at the WHO Regional Office for Europe, based in Copenhagen."}
{"text": "What is the current position of Dr. managementDr at the Ministry of Health, Labour and Welfare in Tokyo, Japan?\n\nDr. managementDr is currently the Deputy Director of the Division of Infectious Diseases at the Ministry of Health, Labour and Welfare in Tokyo, Japan."}
{"text": "What is the current role of Mr. Sini Subrayen at the South African National Blood Service?\n\nMr. Sini Subrayen is a Public Relations Practitioner at the South African National Blood Service."}
{"text": "What role does the National Blood Service of Honduras play in the context of the interregional workshop on blood donor selection and donor counselling?\n\nThe National Blood Service of Honduras, led by its Medical Director, participated in the interregional workshop held in Nairobi, Kenya, from June 21-27, 2011."}
{"text": "What is the role of Dr. Girma at the National Blood Ban?\n\nDr. Girma is the Director of the National Blood Ban."}
{"text": "What is the role of Dr Enayatullah Hashemi in the context of the provided text?\n\nDr Enayatullah Hashemi is the General Manager of Diagnostics at the Ministry of Public Health in Kabul, Afghanistan, and is also serving as the Quality Manager for the National Service, Medical Services Division in Asmara, Eritrea."}
{"text": "What is the role of Mr Mulbah J Kerkula in the National Blood Safety Program?\n\nMr Mulbah J Kerkula is a Field National Blood Safety Program Chief."}
{"text": "What is the role of Ms Maleqhoa within the Ministry of Health and Social Welfare in Maseru?\n\nMs Maleqhoa is the Manager of the Lesotho Service within the Ministry of Health and Social Welfare in Maseru."}
{"text": "What is the professional role of Dr in the Regional Centre located in Embu, Kenya?\n\nThe professional role of Dr in the Regional Centre located in Embu, Kenya is the Medical Officer for the South African National Blood Service."}
{"text": "What is the professional role of Professor MahfoozUrRahman in Punjab, Lahore, Pakistan?\n\nProfessor MahfoozUrRahman is the Director of the Institute of Services in Punjab, Lahore, Pakistan."}
{"text": "Which organization is headquartered in Geneva, Switzerland and focuses on Safety, Health Systems Policies and Workforce?\n\nThe World Health Organization (WHO) is headquartered in Geneva, Switzerland and focuses on Safety, Health Systems Policies and Workforce."}
{"text": "What is Dr. Christie M Reed's current role at the CDC?\n\nDr. Christie M Reed is currently serving as a CDC Resident Advisor for the Presidents Initiative, within the Division of Parasitic Diseases in Monrovia, Liberia."}
{"text": "Who is the Medical Director of the National Service in Nairobi, Kenya?\n\nDr. Oduor is the Medical Director of the National Service in Nairobi, Kenya."}
{"text": "When and where was the workshop on blood donor selection and donor counselling for priority countries in the African and Eastern Mediterranean regions held?\n\nThe workshop was held in June 2011 in Nairobi, Kenya."}
{"text": "What are the primary entities responsible for the implementation of the guidelines for acceptable full-length donor history questionnaire for blood donation screening?\n\nThe primary entities responsible for the implementation of the guidelines are the UK Blood Services Standing Advisory Committee on the Care and Selection of Donors, Joint Professional Advisory Committee, and the UK Blood Services."}
{"text": "What are the eligibility criteria for prospective blood donors according to the American Red Cross Biomedical Services?\n\nThe eligibility criteria for prospective blood donors according to the American Red Cross Biomedical Services are listed alphabetically."}
{"text": "Have you had a meal or snack in the last 4 hours?\n\nYes or No (based on the individual's response to the question in the passage)"}
{"text": "Have you been under a doctor's care or undergone any medical procedures in the past 12 months?\n\nYes, the individual has been under a doctor's care, undergone medical procedures, or received treatment in the past 12 months."}
{"text": "Have you had any close contact with a person with yellow jaundice or viral hepatitis, or received a hepatitis B vaccination?\n\nThe passage does not specify whether the individual has had close contact with a person with yellow jaundice or viral hepatitis, or received a hepatitis B vaccination."}
{"text": "Have you ever received injections of human pituitary growth hormone or fertility medicine?\n\nYes/No (The answer will be directly derived from the individual's response to the question based on the passage provided.)"}
{"text": "Have you ever exchanged money, drugs, goods, or favours in return for sex?\n\nYes or No (based on the individual's experience as per the passage)."}
{"text": "Have you or your sexual partner experienced any of the symptoms such as night sweats, unintentional weight loss, diarrhoea, or swollen glands in the past year?\n\nThe passage does not specify whether the individual or their partner has experienced these symptoms."}
{"text": "In the last 12 months, have you had any immunizations, vaccinations, or jabs?\n\nYes, I have had immunizations, vaccinations, or jabs in the last 12 months."}
{"text": "What diseases will the patient's blood be screened for during the donation process?\n\nThe patient's blood will be screened for HIV, hepatitis B, hepatitis C, and syphilis."}
{"text": "At what age do you confirm you are to donate blood?\n\nI confirm that I am over the age of 18 years."}
